Digital Diabetes Management

Digital Diabetes Management Market Outlook

The global Digital Diabetes Management market is poised to reach approximately $25 billion by 2035, with a compound annual growth rate (CAGR) of around 15% from 2025 to 2035. This growth is primarily driven by the increasing prevalence of diabetes, the rising demand for effective chronic disease management solutions, and advancements in technology that facilitate remote healthcare monitoring. Furthermore, the growing awareness and adoption of digital health tools among patients and healthcare providers are propelling market growth. The integration of artificial intelligence and big data analytics into diabetes management applications is also enhancing patient outcomes and enabling personalized treatment options. As a result, the digital diabetes management market is witnessing robust expansion, making it a critical focus area for stakeholders in the healthcare sector.

Growth Factor of the Market

One of the primary growth factors supporting the expansion of the Digital Diabetes Management market is the increasing global incidence of diabetes, particularly type 2 diabetes. This rise in prevalence has led to a heightened focus on effective management solutions that cater to the needs of patients. The shift towards patient-centered care is driving the adoption of digital tools that empower individuals to take charge of their health. Moreover, advancements in technology, such as wearable devices and mobile health applications, are enabling continuous monitoring of glucose levels and other vital signs, thus improving treatment adherence and outcomes. The integration of telemedicine into diabetes care provides patients with easy access to healthcare professionals, facilitating timely interventions and personalized treatment plans. Lastly, the COVID-19 pandemic has accelerated the demand for digital health solutions, as healthcare systems worldwide have shifted to remote monitoring and virtual consultations to minimize in-person visits.

Key Highlights of the Market

• Expected to reach $25 billion by 2035, with a CAGR of 15%.
• Increased prevalence of diabetes worldwide driving demand.
• Advancements in AI and big data analytics enhance patient outcomes.
• Rise of patient-centered care promotes digital health tool adoption.
• COVID-19 pandemic has accelerated the shift towards telemedicine.

By Product Type

Devices:

Devices represent a significant segment within the Digital Diabetes Management market, encompassing various tools designed to aid in diabetes management, such as continuous glucose monitors (CGMs) and insulin delivery systems. These devices enable real-time monitoring of glucose levels, providing patients and healthcare providers with critical data to make informed decisions. The advancements in technology have led to the development of smart insulin pens and connected glucose meters, which further streamline the diabetes management process. The growing demand for non-invasive and user-friendly devices is expected to drive the growth of this segment, offering patients greater convenience and improving treatment adherence.

Apps:

Applications specifically designed for diabetes management have gained immense popularity as they allow users to track their glucose levels, monitor food intake, and log physical activities. These mobile apps often come equipped with features that enable users to set reminders for medications and appointments, thereby promoting adherence to treatment plans. Furthermore, the integration of social features within these applications fosters a sense of community among users, who can share experiences and tips for managing diabetes. The increasing penetration of smartphones and the growing trend towards self-management are key factors contributing to the rapid expansion of this segment, as more patients seek tools that empower them in their healthcare journey.

Software:

Software solutions play a crucial role in managing diabetes, particularly for healthcare providers who require efficient tools for patient management. These software systems facilitate the collection and analysis of patient data, allowing healthcare professionals to monitor their patients' progress and adjust treatment plans accordingly. Many software platforms also offer telehealth capabilities, enabling remote consultations and follow-ups. The increasing demand for integrated healthcare solutions and the need for comprehensive patient data analytics are driving the growth of this segment. As healthcare systems continue to adopt electronic health records (EHR) and data-driven decision-making, the relevance of specialized diabetes management software will only increase.

Services:

Services in the Digital Diabetes Management market encapsulate a range of offerings from healthcare providers, including telehealth consultations, diabetes education programs, and personalized coaching. These services aim to equip patients with the knowledge and skills necessary to manage their condition effectively. The rise in chronic diseases has heightened the demand for such services, as patients seek ongoing support and guidance. Additionally, many healthcare organizations are now partnering with technology providers to create comprehensive service packages that combine education, monitoring, and patient engagement. This holistic approach to diabetes management is expected to enhance patient outcomes and satisfaction, further driving the growth of this segment.

Diagnostics:

Diagnostic tools within the Digital Diabetes Management market are essential for accurately assessing and monitoring diabetes. These include laboratory tests such as HbA1c tests, as well as point-of-care testing devices that allow for rapid glucose testing. The development of innovative diagnostic technologies, including non-invasive blood glucose monitors, is transforming the landscape of diabetes diagnostics. As healthcare systems continue to prioritize early detection and prevention, the demand for reliable and efficient diagnostic tools is expected to rise significantly. Furthermore, advancements in technology are making diagnostics more accessible, enabling patients to monitor their conditions from home.

By Application

Self-management:

Self-management applications empower patients to take control of their diabetes by providing them with tools and resources to monitor their health. These applications typically include features for tracking glucose levels, dietary intake, and physical activity. By enabling individuals to set personal goals and monitor their progress, self-management tools foster a sense of autonomy among patients, which is crucial for long-term behavior change. The growing emphasis on patient education and engagement is driving demand for these applications, as they help individuals develop better self-care habits and improve overall health outcomes.

Health monitoring:

Health monitoring applications focus on the continuous tracking of vital signs and other health metrics relevant to diabetes management. These applications often integrate with wearable devices to provide real-time data on glucose levels, physical activity, and even stress levels. By offering insights into patients' health, monitoring applications facilitate proactive decision-making and timely interventions. The increasing focus on preventive care and the shift towards personalized medicine are driving the growth of this segment, as healthcare providers seek tools that enable them to monitor their patients more effectively.

Treatment:

Treatment applications are increasingly being utilized to support healthcare professionals in managing diabetes effectively. These applications provide clinicians with the necessary tools to monitor patient adherence to treatment regimens, medication schedules, and therapy adjustments. By facilitating communication between patients and providers, treatment applications enhance the overall quality of care. The emphasis on collaborative care models, where patients and providers work together to manage chronic conditions, is driving growth in this segment. As telemedicine continues to gain traction, the demand for treatment applications that enhance remote care delivery will also rise.

Education:

Education applications are vital for empowering individuals with the knowledge required to manage their diabetes effectively. These applications typically offer resources such as videos, articles, and interactive tools that cover various topics related to diabetes management, including nutrition, exercise, and medication management. The increasing focus on patient education as a cornerstone of effective diabetes management is driving growth in this segment. Additionally, these applications often incorporate gamification elements to engage users, making the learning process more enjoyable and effective.

Remote patient monitoring:

Remote patient monitoring applications enable healthcare providers to track their patients' health metrics from a distance, facilitating timely interventions and personalized care. By utilizing connected devices and applications, healthcare professionals can continuously monitor glucose levels, medication adherence, and lifestyle choices. The demand for remote monitoring solutions has surged, particularly in the wake of the COVID-19 pandemic, as patients seek to minimize in-person visits. This segment is expected to see continued growth as healthcare systems increasingly adopt telehealth strategies to enhance care delivery and improve patient outcomes.

By Distribution Channel

Hospitals:

Hospitals are a significant distribution channel for digital diabetes management solutions, as they serve as primary care settings for patients with chronic conditions. Many hospitals have implemented comprehensive diabetes care programs that integrate digital tools to enhance patient management. These programs often include diabetes education, remote monitoring, and telehealth services, providing patients with a holistic approach to their care. The increasing adoption of electronic health records and data analytics within hospitals is driving the demand for integrated digital solutions, making hospitals critical players in the digital diabetes management landscape.

Specialty Clinics:

Specialty clinics that focus on diabetes management are vital distribution channels for digital solutions, as they provide targeted care to patients with specific needs. These clinics often leverage digital health tools to offer personalized treatment plans, real-time monitoring, and educational resources. By creating a focused environment for diabetes care, specialty clinics can effectively utilize digital solutions to improve patient outcomes and enhance engagement. The growing awareness of diabetes management and the demand for specialized care are driving growth in this segment, as more patients seek tailored solutions for their conditions.

Retail Pharmacies:

Retail pharmacies are increasingly becoming distribution points for digital diabetes management solutions, offering patients accessible resources for managing their condition. Many pharmacies now provide diabetes education programs, health screenings, and digital tools that assist patients in tracking their health metrics. The convenience of obtaining medications along with digital solutions in one location is appealing to patients, driving demand in this segment. As retail pharmacies continue to expand their health services, the integration of digital diabetes management solutions will play a crucial role in enhancing patient care and engagement.

Online Platforms:

Online platforms for digital diabetes management solutions are rapidly gaining traction, providing patients access to a variety of tools and resources for managing their condition. These platforms often offer a mix of educational content, monitoring tools, and telehealth services, making it convenient for patients to receive support from the comfort of their homes. The increasing penetration of the internet and smartphones is driving the growth of online platforms, as more individuals seek digital solutions for their healthcare needs. Additionally, the ability to connect with healthcare professionals through these platforms enhances the overall patient experience, making online channels a vital component of the digital diabetes management market.

Homecare Settings:

Homecare settings play a crucial role in the distribution of digital diabetes management solutions, as many patients prefer to manage their conditions from home. The integration of digital tools into homecare allows for continuous monitoring and real-time feedback, promoting better self-management. Patients can utilize various devices and applications to track their health metrics and communicate with healthcare providers. The growing emphasis on patient-centered care and the shift towards home-based healthcare are driving demand in this segment, as more individuals seek to manage their diabetes effectively in their own environments.

By Technology

Artificial Intelligence:

Artificial Intelligence (AI) is revolutionizing the Digital Diabetes Management market by enabling more personalized and data-driven approaches to diabetes care. AI algorithms can analyze vast amounts of patient data to identify patterns, predict complications, and recommend tailored treatment plans. These insights can significantly enhance patient outcomes by allowing healthcare providers to make informed decisions. Additionally, AI-powered chatbots and virtual assistants are being integrated into digital platforms to provide real-time support and answer patients' queries. The growing adoption of AI in healthcare is expected to spur further innovations in diabetes management, resulting in improved patient engagement and satisfaction.

Wearable Technology:

Wearable technology has become an integral part of digital diabetes management, allowing patients to monitor their health metrics continuously. Devices such as smartwatches and fitness trackers can track glucose levels, physical activity, and other vital signs, providing users with valuable insights into their health. These wearables often integrate with mobile applications, enabling seamless data sharing with healthcare providers. The increasing popularity of wearable technology among health-conscious consumers is driving growth in this segment. As technology continues to advance, the potential for innovative wearables to revolutionize diabetes management will only increase.

Telemedicine:

Telemedicine has emerged as a transformative technology in the Digital Diabetes Management market, enabling remote consultations and monitoring for patients. This technology allows healthcare providers to connect with patients in real-time, offering guidance and support without the need for in-person visits. The convenience of telemedicine is particularly appealing to individuals with chronic conditions, who may struggle with frequent office visits. The COVID-19 pandemic has accelerated the adoption of telemedicine in diabetes care, as healthcare systems sought to minimize in-person interactions. As telemedicine continues to evolve, it is expected to play a vital role in enhancing diabetes management and patient care.

Big Data Analytics:

Big Data Analytics is a game-changer in the Digital Diabetes Management market, providing healthcare providers with robust tools for analyzing patient data and deriving actionable insights. By leveraging large datasets, providers can identify trends, track patient adherence, and evaluate treatment effectiveness. The ability to analyze and interpret complex data is crucial for developing personalized treatment plans and improving patient outcomes. As healthcare systems increasingly adopt data-driven strategies, the demand for big data analytics solutions will continue to grow, driving advancements in diabetes management.

Internet of Things (IoT):

The Internet of Things (IoT) is fundamentally transforming diabetes management by connecting devices, applications, and healthcare providers in real-time. IoT-enabled devices can communicate with one another, allowing for seamless data sharing and continuous monitoring of patients' health metrics. This connectivity enables healthcare providers to track patients' progress, adjust treatment plans as necessary, and engage with patients more effectively. The increasing adoption of IoT in healthcare is driving innovation in diabetes management, as it allows for more proactive and personalized care. The growing need for integrated healthcare solutions will further accelerate the adoption of IoT technologies in the diabetes management landscape.

By Region

The North American region holds a dominant position in the Digital Diabetes Management market, accounting for approximately 45% of the global market share in 2023. This growth can be attributed to the high prevalence of diabetes, advanced healthcare infrastructure, and the increasing adoption of digital health solutions among healthcare providers and patients. The region is also witnessing significant investments in technology and innovation, further propelling market growth. The CAGR for this region is projected to be around 12% over the next decade, driven by a rising focus on diabetes management and the integration of advanced digital tools into care delivery.

Europe closely follows North America, capturing around 30% of the market share in 2023. The growing emphasis on preventive healthcare and the increasing awareness of diabetes management strategies are key factors contributing to market growth in this region. Furthermore, European countries are investing in digital health initiatives to improve patient outcomes and reduce healthcare costs. The Asia Pacific region is also emerging as a significant market for digital diabetes management, driven by the rising prevalence of diabetes and growing demand for telehealth services. The CAGR for this region is expected to exceed 15%, as healthcare systems evolve to incorporate more digital solutions to enhance patient care.

Opportunities

The Digital Diabetes Management market presents several opportunities for stakeholders, particularly in the realm of product innovation. As technology continues to advance, there is a growing demand for more sophisticated digital tools that cater to the diverse needs of diabetic patients. Companies that invest in research and development to create innovative solutions—such as advanced wearable devices, AI-driven applications, and integrated telehealth platforms—are likely to gain a competitive edge in the market. Furthermore, the increasing focus on preventive care and personalized medicine provides opportunities for businesses to develop targeted solutions that address specific patient needs, ultimately leading to improved health outcomes.

In addition to product innovation, there is considerable potential for market expansion in emerging economies. As healthcare infrastructure continues to improve in regions such as Asia Pacific and Latin America, the demand for digital diabetes management solutions is expected to rise significantly. Companies that strategically enter these markets and form partnerships with local healthcare providers can capitalize on the growing demand for effective diabetes care. Additionally, government initiatives aimed at promoting digital health adoption and improving diabetes management will further fuel market growth in these regions. By leveraging these opportunities, stakeholders can effectively contribute to the advancement of diabetes care on a global scale.

Threats

Despite the promising growth prospects for the Digital Diabetes Management market, several threats could hinder its expansion. One significant challenge is the issue of data privacy and security. As more patients utilize digital platforms to manage their diabetes, the potential for data breaches and unauthorized access to sensitive health information increases. Healthcare providers and technology companies must prioritize data security and implement robust cybersecurity measures to protect patient information. Failure to adequately address these concerns could lead to a decline in consumer trust and hinder the adoption of digital health solutions, ultimately impacting market growth.

Another threat to the Digital Diabetes Management market is the potential for regulatory hurdles. Regulatory bodies are continually evolving their guidelines and standards regarding digital health solutions, which can create challenges for companies seeking to bring new products to market. Navigating the complex regulatory landscape can be time-consuming and costly, particularly for smaller companies with limited resources. Additionally, the rapid pace of technological change may outstrip regulatory frameworks, leading to uncertainty and potential delays in product approval. To succeed in this environment, companies must stay informed of regulatory developments and be prepared to adapt their strategies accordingly.

Competitor Outlook

• Dexcom Inc.
• Abbott Laboratories
• Medtronic Plc
• Roche Diabetes Care
• Johnson & Johnson
• Ascensia Diabetes Care
• Diabetes Care Group
• Omada Health
• MySugr GmbH
• Glooko Inc.
• WellDoc Inc.
• Livongo Health, Inc.
• BlueLoop
• Glucose Buddy
• One Drop, Inc.

The competitive landscape of the Digital Diabetes Management market is characterized by a diverse range of established players and emerging startups, each striving to capture market share through innovative solutions and strategic partnerships. Major companies such as Dexcom and Abbott Laboratories are at the forefront of this market, leveraging their expertise in diabetes devices and monitoring technologies. These organizations are continually investing in research and development to enhance their product offerings, aiming to provide patients with more effective and user-friendly solutions. Additionally, collaborations with healthcare providers and technology firms are enabling these companies to expand their reach and deliver integrated diabetes management solutions.

Emerging players, such as Livongo Health and Omada Health, are disrupting the market with their digital health platforms that emphasize personalized care and remote monitoring. These companies are harnessing technology to provide comprehensive diabetes management solutions, focusing on patient engagement and support. Their innovative approaches have garnered attention from investors and healthcare providers alike, positioning them for significant growth in the coming years. The competitive landscape is further intensified by the increasing emphasis on telehealth and digital health solutions, with companies focusing on developing comprehensive platforms that combine education, monitoring, and treatment.

In addition to established companies and startups, the Digital Diabetes Management market is also witnessing the entry of tech giants seeking to leverage their capabilities in healthcare. Companies like Google and Apple are exploring opportunities in the diabetes management space, utilizing their technological expertise to develop innovative solutions that enhance patient care. These entrants pose a significant threat to existing players, as they bring considerable resources and brand recognition to the market. As competition intensifies, companies will need to differentiate their offerings and focus on delivering value to patients and healthcare providers to maintain a competitive edge.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 BlueLoop
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Dexcom Inc.
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Glooko Inc.
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 MySugr GmbH
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Omada Health
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 WellDoc Inc.
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Glucose Buddy
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Medtronic Plc
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 One Drop, Inc.
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Johnson & Johnson
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Abbott Laboratories
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Diabetes Care Group
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Roche Diabetes Care
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Livongo Health, Inc.
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Ascensia Diabetes Care
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Digital Diabetes Management Market, By Technology
    • 6.1.1 Artificial Intelligence
    • 6.1.2 Wearable Technology
    • 6.1.3 Telemedicine
    • 6.1.4 Big Data Analytics
    • 6.1.5 Internet of Things
  • 6.2 Digital Diabetes Management Market, By Application
    • 6.2.1 Self-management
    • 6.2.2 Health monitoring
    • 6.2.3 Treatment
    • 6.2.4 Education
    • 6.2.5 Remote patient monitoring
  • 6.3 Digital Diabetes Management Market, By Product Type
    • 6.3.1 Devices
    • 6.3.2 Apps
    • 6.3.3 Software
    • 6.3.4 Services
    • 6.3.5 Diagnostics
  • 6.4 Digital Diabetes Management Market, By Distribution Channel
    • 6.4.1 Hospitals
    • 6.4.2 Specialty Clinics
    • 6.4.3 Retail Pharmacies
    • 6.4.4 Online Platforms
    • 6.4.5 Homecare Settings

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Digital Diabetes Management Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Digital Diabetes Management market is categorized based on

By Product Type

• Devices
• Apps
• Software
• Services
• Diagnostics

By Application

• Self-management
• Health monitoring
• Treatment
• Education
• Remote patient monitoring

By Distribution Channel

• Hospitals
• Specialty Clinics
• Retail Pharmacies
• Online Platforms
• Homecare Settings

By Technology

• Artificial Intelligence
• Wearable Technology
• Telemedicine
• Big Data Analytics
• Internet of Things

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Dexcom Inc.
• Abbott Laboratories
• Medtronic Plc
• Roche Diabetes Care
• Johnson & Johnson
• Ascensia Diabetes Care
• Diabetes Care Group
• Omada Health
• MySugr GmbH
• Glooko Inc.
• WellDoc Inc.
• Livongo Health, Inc.
• BlueLoop
• Glucose Buddy
• One Drop, Inc.